Research Fellow, MD, PhD
- Translational Radiation Oncology
Following my training in Clinical Oncology at the University of Pisa, from June 2008 to December 2020, I held the position of consultant at Pisa University Hospital, where, from 02/01/2015 to 26/12/2020, I looked after the neuro-oncology multidisciplinary team. I hold a PhD in Clinical Pharmacology, and, in the latter years, my research has been focused on translational studies carried out in brain cancer patients, a new growing field of study in oncology.
Thanks to a fellowship cofounded by the Marie Curie Actions and the Italian Association on Cancer Research (iCARE-2), since January 2021, I have been working for the Department of Oncology of the University of Oxford (Computational Biology and Integrative Genomics lab, headed by Professor Francesca Buffa). By combining artificial intelligence with liquid biopsy, my research aims to explore new approaches for brain tumor patients.
Nonrandomised controlled trial in recurrent glioblastoma patients: the promise of autologous tumour lysate-loaded dendritic cell vaccination.
Pasqualetti F. and Zanotti S., (2023), Br J Cancer
Correlation of Pre- and Post-radio-chemotherapy MRI Texture Features With Tumor Response in Rectal Cancer.
Paiar F. et al, (2023), Anticancer Res, 43, 781 - 788
The Prognostic Impact of Gender, Therapeutic Strategies, Molecular Background, and Tumor-Infiltrating Lymphocytes in Glioblastoma: A Still Unsolved Jigsaw.
Innocenti L. et al, (2023), Genes, 14
Radiomics-Based Inter-Lesion Relation Network to Describe [18F]FMCH PET/CT Imaging Phenotypes in Prostate Cancer.
Cavinato L. et al, (2023), Cancers (Basel), 15
Impact of temporalis muscle thickness in elderly patients with newly diagnosed glioblastoma treated with radio or radio-chemotherapy.
Pasqualetti F. et al, (2022), La Radiologia medica